FOR THE SECOND YEAR RUNNING NOVACYT WINS TECHNOLOGY FAST 50 AWARD

Novacyt Technology Fast 50 Award 2017 ENG Paris, France and Cambridge, UK – 7 November 2017 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces it has won, for the second consecutive year, the Ile-de-France award of the Deloitte Technology Fast 50 French programme, an initiative that rewards fast

Visit Page

SETTLEMENT AND REDEMPTION OF ALL OUTSTANDING YORKVILLE CONVERTIBLE BONDS

Settlement and redemption of convertible bonds with Yorkville ENG Removes potentially dilutive instrument Strengthened balance sheet supports future growth

Visit Page

ADMISSION AND FIRST DAY OF DEALINGS ON AIM

Novacyt admission and first day of dealings AIM ENG Paris, France and Cambridge, UK – 1st November 2017 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the admission of the Company’s Shares (the “Enlarged Share Capital”) to trading on AIM, a market operated by the London

Visit Page